Monitoring the responsiveness of T and antigen presenting cell compartments in breast cancer patients is useful to predict clinical tumor response to neoadjuvant chemotherapy

by David A. Bernal-Estévez, Oscar García, Ramiro Sánchez, Carlos A. Parra-López
Published 2018-01-01

Autologous Dendritic Cells in Combination With Chemotherapy Restore Responsiveness of T Cells in Breast Cancer Patients: A Single-Arm Phase I/II Trial

by David A. Bernal-Estévez, Mauren A. Ortíz Barbosa, Paola Ortíz-Montero, Claudia Cifuentes, Ramiro Sánchez, Carlos A. Parra-López
Published 2021-08-01